02:22
Embla cuts GLP-1 costs in half and delivers 16.7% average weight loss by offering whole-person care through high-quality behavioral coaching and a low-dose GLP-1 treatment.
Transcript:
What is Embla?
So GLP-1 demand is exploding and employers are stuck between two really bad options. Skip the meds or rely on them entirely. Neither really works. Most programs treat obesity like a dosage problem. We treat it like a behavioral problem with a better and much smaller dose; so Embla offers a smarter third path. We are built by GLP-1 researchers and Danish health tech entrepreneurs with a backg...
Posted July 9, 2025
